Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	1.4	3.09	11.25	14.55	19.99	3.02
Cash & Short-Term Investments	1.4	3.09	11.25	14.55	19.99	3.02
Cash Growth	-83.52%	-72.49%	-22.69%	-27.21%	560.69%	-
Other Receivables	0.25	-	-	-	-	0
Receivables	0.25	-	-	-	-	0
Prepaid Expenses	0.31	0.41	0.42	1.03	1.67	-
Total Current Assets	1.96	3.51	11.67	15.58	21.65	3.03
Other Long-Term Assets	0.51	0.57	-	-	-	-
Total Assets	2.47	4.07	11.67	15.58	21.65	3.03
Accounts Payable	0.25	0.16	0.53	0.38	0.11	-
Accrued Expenses	0.32	0.1	0.53	0.13	0.13	0.02
Short-Term Debt	-	-	-	-	-	0.2
Total Current Liabilities	0.57	0.26	1.07	0.51	0.24	0.22
Total Liabilities	0.57	0.26	1.07	0.51	0.24	0.22
Common Stock	0.03	0.03	0.03	0.02	0.02	0.01
Additional Paid-In Capital	69.48	69.19	67.78	60.51	60.03	-
Retained Earnings	-67.6	-65.4	-57.2	-45.47	-38.64	-0.18
Total Common Equity	1.9	3.81	10.6	15.07	21.41	-0.17
Shareholders' Equity	1.9	3.81	10.6	15.07	21.41	2.8
Total Liabilities & Equity	2.47	4.07	11.67	15.58	21.65	3.03
Total Debt	-	-	-	-	-	0.2
Net Cash (Debt)	1.4	3.09	11.25	14.55	19.99	2.82
Net Cash Growth	-83.52%	-72.49%	-22.69%	-27.21%	607.78%	-
Net Cash Per Share	0.05	0.12	0.45	0.62	1.47	0.24
Filing Date Shares Outstanding	25.93	25.93	25.63	23.37	23.34	12
Total Common Shares Outstanding	25.93	25.93	25.63	23.34	23.34	12
Working Capital	1.39	3.25	10.6	15.07	21.41	2.8
Book Value Per Share	0.07	0.15	0.41	0.65	0.92	-0.01
Tangible Book Value	1.9	3.81	10.6	15.07	21.41	-0.17
Tangible Book Value Per Share	0.07	0.15	0.41	0.65	0.92	-0.01

Source: S&P Capital IQ. Standard template. Financial Sources.